Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1982 Nov;38(2):645–650. doi: 10.1128/iai.38.2.645-650.1982

Capacity of influenza virus-monoclonal antibody mixtures to stimulate memory and cytotoxic T lymphocyte populations.

N Greenspan, J L Hurwitz, P C Doherty
PMCID: PMC347788  PMID: 6982868

Abstract

The magnitude of the cytotoxic T lymphocyte response in both immunologically naive mice and in mice primed with a serologically non-cross-reactive influenza A virus was greatly diminished if the virus used for challenge was first incubated with excess hemagglutinin-specific monoclonal antibody. However, the level of T cell stimulation was, when compared with virus stocks that are simply diluted, greater than would be expected from the infectivity titer remaining after exposure to the monoclonal antibody. Also, mice given mixtures of virus and monoclonal antibody were primed for a secondary cytotoxic T lymphocyte response, the frequency of memory T cells being approximately fourfold lower than that found for animals injected with virus alone. The possibility that such virus-antibody mixtures might be of value for immunization is worth further investigation.

Full text

PDF
648

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Braciale T. J., Yap K. L. Role of viral infectivity in the induction of influenza virus-specific cytotoxic T cells. J Exp Med. 1978 Apr 1;147(4):1236–1252. doi: 10.1084/jem.147.4.1236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Doherty P. C., Effros R. B., Bennink J. Heterogeneity of the cytotoxic response of thymus-derived lymphocytes after immunization with influenza viruses. Proc Natl Acad Sci U S A. 1977 Mar;74(3):1209–1213. doi: 10.1073/pnas.74.3.1209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Doherty P. C., Gerhard W. Breakdown of the blood--cerebrospinal fluid barrier to immunoglobulin in mice injected intracerebrally with a neurotropic influenza A virus. Post-exposure treatment with monoclonal antibody promotes recovery. J Neuroimmunol. 1981 Sep;1(3):227–237. doi: 10.1016/0165-5728(81)90027-8. [DOI] [PubMed] [Google Scholar]
  4. Doherty P. C., Zinkernagel R. M. T-cell-mediated immunopathology in viral infections. Transplant Rev. 1974;19(0):89–120. doi: 10.1111/j.1600-065x.1974.tb00129.x. [DOI] [PubMed] [Google Scholar]
  5. Effros R. B., Doherty P. C., Gerhard W., Bennink J. Generation of both cross-reactive and virus-specific T-cell populations after immunization with serologically distinct influenza A viruses. J Exp Med. 1977 Mar 1;145(3):557–568. doi: 10.1084/jem.145.3.557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. FAZEKAS DE ST GROTH S., WHITE D. O. An improved assay for the infectivity of in influenza viruses. J Hyg (Lond) 1958 Mar;56(1):151–162. doi: 10.1017/s0022172400037621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Frankel M. E., Gerhard W. The rapid determination of binding constants for antiviral antibodies by a radioimmunoassay. An analysis of the interaction between hybridoma proteins and influenza virus. Mol Immunol. 1979 Feb;16(2):101–106. doi: 10.1016/0161-5890(79)90051-8. [DOI] [PubMed] [Google Scholar]
  8. Gerhard W., Yewdell J., Frankel M. E., Webster R. Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies. Nature. 1981 Apr 23;290(5808):713–717. doi: 10.1038/290713a0. [DOI] [PubMed] [Google Scholar]
  9. Greenspan N., Doherty P. C. Modification of cytotoxic T-cell response patterns by administration of hemagglutinin-specific monoclonal antibodies to mice infected with influenza A viruses. Hybridoma. 1982;1(2):149–159. doi: 10.1089/hyb.1.1982.1.149. [DOI] [PubMed] [Google Scholar]
  10. Kilbourne E. D. Future influenza vaccines and the use of genetic recombinants. Bull World Health Organ. 1969;41(3):643–645. [PMC free article] [PubMed] [Google Scholar]
  11. Reiss C. S., Schulman J. L. Cellular immune responses of mice to influenza virus vaccines. J Immunol. 1980 Nov;125(5):2182–2188. [PubMed] [Google Scholar]
  12. Ritz J., Schlossman S. F. Utilization of monoclonal antibodies in the treatment of leukemia and lymphoma. Blood. 1982 Jan;59(1):1–11. [PubMed] [Google Scholar]
  13. Rodgers B., Mims C. A. Interaction of influenza virus with mouse macrophages. Infect Immun. 1981 Feb;31(2):751–757. doi: 10.1128/iai.31.2.751-757.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Sherman L. A. Dissection of the B10.D2 anti-H-2Kb cytolytic T lymphocyte receptor repertoire. J Exp Med. 1980 Jun 1;151(6):1386–1397. doi: 10.1084/jem.151.6.1386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sweet C., Smith H. Pathogenicity of influenza virus. Microbiol Rev. 1980 Jun;44(2):303–330. doi: 10.1128/mr.44.2.303-330.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Webster R. G., Askonas B. A. Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice. Eur J Immunol. 1980 May;10(5):396–401. doi: 10.1002/eji.1830100515. [DOI] [PubMed] [Google Scholar]
  17. Weiss A., Brunner K. T., MacDonald H. R., Cerottini J. C. Antigenic specificity of the cytolytic T lymphocyte response to murine sarcoma virus-induced tumors. III. Characterization of cytolytic T lymphocyte clones specific for Moloney leukemia virus-associated cell surface antigens. J Exp Med. 1980 Nov 1;152(5):1210–1225. doi: 10.1084/jem.152.5.1210. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES